Log In
Print
BCIQ
Print
Print this Print this
 

NI-0501

  Manage Alerts
Collapse Summary General Information
Company Novimmune S.A.
DescriptionHuman mAb against interferon (IFN) gamma
Molecular Target Interferon (IFN) gamma
Mechanism of ActionAntibody
Therapeutic ModalityBiologic: Antibody
Latest Stage of DevelopmentPhase II
Standard Indication Hematology (unspecified)
Indication DetailsTreat hemophagocytic lymphohistiocytosis (HLH)
Regulatory Designation

EU - Orphan Drug (Treat hemophagocytic lymphohistiocytosis (HLH))

Partner


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today